5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D001230:Aspergillus / Q000187:drug effects; D002175:Candida; D002177:Candidiasis; D002648:Child; D003453:Cryptococcosis; D003596:Cytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D005260:Female; D005461:Fluorine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D006801:Humans; D007223:Infant; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D008297:Male; D008581:Meningitis / Q000188:drug therapy / Q000209:etiology; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy / Q000209:etiology
D000935:Antifungal Agents; D005461:Fluorine; D003596:Cytosine